Hamdan Hamdan Z, Kubbara Eman, Adam Amar M, Hassan Onab S, Suliman Sarah O, Adam Ishag
Department of Biochemistry and Molecular Biology, Faculty of Medicine, Al-Neelain University, P.O. Box 12702, Khartoum, Sudan.
Faculty of Pharmacy, Al-Yarmouk University College, Khartoum, Sudan.
Ann Clin Microbiol Antimicrob. 2015 Apr 21;14:26. doi: 10.1186/s12941-015-0082-4.
Patients with diabetes mellitus (DM) are more susceptible to urinary tract infection (UTI) than non-diabetics. Due to the emergence of multidrug resistant (MDR) uropathogenic strains, the choice of antimicrobial agent is restricted. This study investigated the epidemiology of UTI, antimicrobial susceptibility, and resistance patterns of bacterial isolates from adult diabetic patients.
A cross-sectional study was conducted at Khartoum Hospital, Sudan during the period of March - September 2013. Consecutive patients (men and women) were approached to participate in the study, irrespective of UTI symptoms. Socio-demographic and clinical data were obtained from each participant using pre-tested questionnaires. Clean-catch, midstream urine samples were collected and cultured for UTI diagnosis and antimicrobial susceptibility. Symptomatic bacteriuria was defined as a positive urine culture (≥10(5) colony-forming units [CFU]/mL of a single bacterial species) from patients with symptoms associated with UTI; asymptomatic bacteriuria was defined as a positive urine culture from patients without symptoms associated with UTI.
A total of 200 diabetic patients were enrolled, 121 (60.5%) men and 79 (39.5%) women; 193 (96.5%) had type II DM. The overall prevalence of UTI was 39 (19.5%). Among the total population, 17.1% and 20.9% had symptomatic and asymptomatic bacteriuria, respectively. According to multivariate logistic regression, none of the investigated factors (age, sex, type of DM and duration) were associated with UTI. The predominant isolates were Escherichia coli (22, [56.4%]), and Klebsiella pneumoniae, [9, (23%)]. Eight of 22 E. coli, four of nine K. pneumoniae and one of five Enterococcus faecalis isolates originated from symptomatic patients. Six, four, three, and two of 22 E. coli isolates showed resistance to ampicillin, co-trimoxazole, nitrofurantoin, and amoxicillin-clavulanic acid, respectively. Two, two, one and one of nine K. pneumoniae isolates were resistant to ampicillin, co-trimoxazole, cephalexin, and amoxicillin-clavulanic acid. All 22 E. coli isolates were sensitive (100%) to gentamicin and cephalexin. All nine K. pneumoniae were sensitive to gentamicin (100%) and 88.8% were sensitive to cephalexin.
In Sudan, about one-fifth of diabetic patients have UTI. E. coli is the most frequent isolate followed by K. pneumoniae.
糖尿病患者比非糖尿病患者更容易发生尿路感染(UTI)。由于多重耐药(MDR)尿路致病性菌株的出现,抗菌药物的选择受到限制。本研究调查了成年糖尿病患者UTI的流行病学、抗菌药物敏感性以及细菌分离株的耐药模式。
2013年3月至9月期间在苏丹喀土穆医院进行了一项横断面研究。连续纳入患者(男性和女性)参与研究,无论其是否有UTI症状。使用预先测试的问卷从每位参与者处获取社会人口统计学和临床数据。收集清洁中段尿样本并进行培养,以诊断UTI并检测抗菌药物敏感性。有症状菌尿症定义为有UTI相关症状患者的尿培养阳性(单一细菌种类≥10⁵菌落形成单位[CFU]/mL);无症状菌尿症定义为无UTI相关症状患者的尿培养阳性。
共纳入200例糖尿病患者,其中男性121例(60.5%),女性79例(39.5%);193例(96.5%)为2型糖尿病。UTI的总体患病率为39例(19.5%)。在总人群中,有症状菌尿症和无症状菌尿症的患病率分别为17.1%和20.9%。根据多因素逻辑回归分析,所调查的因素(年龄、性别、糖尿病类型和病程)均与UTI无关。主要分离株为大肠埃希菌(22株,[56.4%])和肺炎克雷伯菌(9株,[23%])。22株大肠埃希菌中的8株、9株肺炎克雷伯菌中的4株以及5株粪肠球菌中的1株分离自有症状患者。22株大肠埃希菌分离株中,分别有6株、4株、3株和2株对氨苄西林、复方新诺明、呋喃妥因和阿莫西林 - 克拉维酸耐药。9株肺炎克雷伯菌分离株中,分别有2株、2株、1株和1株对氨苄西林、复方新诺明、头孢氨苄和阿莫西林 - 克拉维酸耐药。所有22株大肠埃希菌分离株对庆大霉素和头孢氨苄均敏感(100%)。所有9株肺炎克雷伯菌对庆大霉素均敏感(100%),对头孢氨苄的敏感率为88.8%。
在苏丹,约五分之一的糖尿病患者患有UTI。大肠埃希菌是最常见的分离株,其次是肺炎克雷伯菌。